Scientific and strategic consulting
DR. RIETHMÜLLER M/R/S is able to provide all of the services listed below. Please feel free to
contact us should you require any additional information.
Preclinic and clinic
The company prepares and evaluates detailed development plans, including pharmaceutical
development, pharmacology, toxicology, pharmacokinetics and clinical Phases I to IV. We respect
ICH-GMP, GLP, GCP and regional guidelines (FDA, CHMP).
Cost calculations of developments are performed.
Services and scientific areas
We set up files for
Marketing authorization approval
Orphan drug designation
In Europe we prepare submissions/notifications to conduct clinical studies
Investigational Medicinal Product Dossier (IMPD)
For the successful performance of clinical studies we cooperate with highly qualified
Clinical investigators and experts
CROs: monitoring of studies, statistics
Clinical and preclinical activities have been carried out by us in numerous benign and oncologic indications, e.g. CNS,
cardiovascular, respiratory, metabolic, endocrine, infectious, immunologic, gastro-intestinal, gynecologic
and urologic diseases, and in the treatment of pain.
Longstanding experience has been gained by the team with new small chemical entities, recombinant drugs, antibodies,
generics, and phytopharmaceuticals.